Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-12-10 00:00:00 ET · period of report 2024-12-06 · accession 0001415889-24-028844 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-10 | 2024-12-06+ | KNSA | Ragosa Mark | CFO | M - OptEx | $11.06 | +21.3K | 41.8K | +103% | +$235.2K |
| DM | 2024-12-10 | 2024-12-06+ | KNSA | Ragosa Mark | CFO | S - Sale+OE | $21.34 | -27.8K | 23.0K | -55% | -$594.0K |
| DM | 2024-12-10 | 2024-12-06+ | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -21.3K | 24.5K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2024-12-06 | M | A | 2,406 | $10.76 | 25,364 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2024-12-09 | M | A | 18,860 | $11.10 | 41,818 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2024-12-09 | S | D | 18,860 | $21.38 | 22,958 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $21.25 and $21.755. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 4 | Common | Class A Ordinary Share | 2024-12-06 | S | D | 8,969 | $21.27 | 22,958 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $21.25 and $21.31. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Derivative | Share Option | 2024-12-09 | M | D | 18,860 | $0.00 | 21,552 | D | $11.10 · — to 2032-04-06 | 18,860 Class A Ordinary Share | (F5) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 8, 2022. |
| 6 | Derivative | Share Option | 2024-12-06 | M | D | 2,406 | $0.00 | 24,528 | D | $10.76 · — to 2033-03-31 | 2,406 Class A Ordinary Share | (F4) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 2, 2023. |